The Ras signal transduction pathway

Cancer and Metastasis Reviews

Volumn 13, Issue 1, 1994, Pages 67-89

  Khosravi Far, Roya ^a   Der, Channing J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

actin; Ras proteins; Rho family; tyrosine kinases

Indexed keywords

ACTIN; CELL SURFACE RECEPTOR; GLYCOPROTEIN GP 140; PROTEIN TYROSINE KINASE;

CANCER THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOSKELETON; DNA FLANKING REGION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; MALIGNANT TRANSFORMATION; MITOGENESIS; ONCOGENE RAS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMAL; CELL DIFFERENTIATION; CELL DIVISION; GENE EXPRESSION REGULATION; GENES, RAS; GTP-BINDING PROTEINS; HUMAN; MAMMALS; MUTATION; NEOPLASMS; ONCOGENES; PROTO-ONCOGENE PROTEIN P21(RAS); PROTO-ONCOGENES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027955218     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/BF00690419     Document Type: Article

References (221)

1. ras genes
2. ras oncogenes in human cancer: a review
3. Function of Ras as a molecular switch in signal transduction
4. Regulation of p21ras activity
5. Regulators and effectors of ras proteins
6. Regulatory mechanisms for ras proteins
7. Ras p21: effects and regulation
8. GTPase activating proteins
9. Signal transduction through small GTPases - a tale of two GAPS
10. Exchange rate mechanisms
11. A signal chain of events
12. Signal transduction and the fate of the R7 photoreceptor in Drosophila
13. Signal transduction during C. elegans vulval development
14. RAS genes in Saccharomyces cerevisiae: signal transduction in search of a pathway
15. Triggering signaling cascades by receptor tyrosine kinases
16. Function for ras in sight
17. How receptors turn Ras on
18. Ras in signal transduction
19. SH2 and SH3 domains: from structure to function
20. The many roads that lead to ras
21. Ras-related GTPases and the cytoskeleton
22. Rac and rho in tune
23. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells
24. Transgenic models of tumor development
25. ras oncogenes in chemical carcinogenis
26. ras activation in experimental carcinogenesis
27. The GTPase superfamily: a conserved switch for diverse cell functions
28. The GTPase superfamily: conserved structure and molecular mechanism
29. NF is enough of GAP
30. Regulation of ras p21 by GTPase activating proteins
31. Molecular cloning of two types of GAP complementary DNA from human placenta
32. GTPase activating protein (GAP) interacts with the p21 ras effector binding domain
33. The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product
34. GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K+ channel currents
35. A novel arachidonic acidselective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP
36. A putative modular domain present in diverse signaling proteins
37. SH2 and SH3 domains
38. Signalling through SH2 and SH3 domains
39. Quantitative analysis of SH2 domain binding
40. Identification of a ten-amino acid proline-rich SH3 binding site
41. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins
42. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients
43. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
44. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations
45. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae
46. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
47. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins
48. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines
49. NF1: a prevalent cause of tumorigenesis in human cancers?
50. The target sets the tempo
51. GAP as ras effector or negative regulator?
52. ras GTPase activating protein: signal transmitter and signal terminator
53. Suppression of c-ras transformationon by GTPase-activating protein
54. Modulation of guanine nucleotides bound to ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP)
55. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
56. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
57. Cloning of bovine GAP and its interaction with oncogenic ras p21
58. Interaction between guanosine triphosphatase activating protein (GAP) and the effector domain of ras encoded proteins
59. A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1
60. Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/‘effector’ domain
61. A ras-related gene with transformation suppressor activity
62. Ras p21 and GAP inhibit coupling of muscarinic receptors to atrialT channels
63. Differential antagonism of Ras biological activity by catalytic and Src homology domains of Ras GTPase activation protein
64. Binding of SH2 domains of phospholipase Cdeltal, GAP and Src to activated growth factor receptors
65. Src homology region 2 domains direct protein-protein interactions in signal transduction
66. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways
67. Phosphorylation of GAP and GAP-associated proteis by transforming and mitogenic tyrosine kinases
68. GTPase-activating protein SH2-SH3 domains induce gene expression in a Ras-dependent fashion
69. Implication of GAP in ras-dependent transactivation of a polyoma enhancer sequence
70. Identification of the SH3 domain of GAP as an essential sequence for Ras-GAP-mediated signaling
71. Differential regulation of ras-GAP and neurofibromatosis gene product activities
72. Neurofibromatosis type 1 gene mutations in neuroblastoma
73. A cytosolic protein catalyzes the release of GDP from p21ras
74. A novel membrane factor stimulates guanine nucleotide exchange reaction of ras proteins
75. Identification of nucleotide exchange-promoting activity for p21 ras
76. The S. cerevisiae CDC25 gene product regulates the RAS/Adenylate cyclase pathway
77. The CDC25 protein of Saccharomyces cerevisiae promotes exchange of guanine nucleotides bound to ras
78. Homologous activators of ras in fission and budding yeast
79. The Son of sevenless gene product: a putative activator of ras
80. Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for Ras p21
81. Identification of a mammalian gene structurally and functionally related to the CDC25 gene of Saccharomyces cerevisiae
82. Cloning by functional complementation of a mouse cDNA encoding a homolog of CDC25, a Saccharomyces cerevisiae Ras activator
83. Isolation of multiple mouse cDNAs with coding homology to Saccharomyces cerevisiae CDC25: identification of a region related to Bcr, Vav, Dbl and CDC24
84. Identification of murine homologues of the Drosophila Son of sevenless gene: potential aivators of ras
85. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2
86. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation
87. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells
88. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization
89. Isolation of a new human oncogene from a diffuse B-cell lymphoma
90. Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product
91. Molecular cloning of the cDNA for stimulatory GDP/GTP exchange protein for smg p21s (ras p21-like small GTP-binding proteins) and characterization of stimulatory GDP/GTP exchange protein
92. A stimulatory GDP/GTP exchange protein for smg p21 is active on the posttranslationally processed form of c-Ki- ras p21 and rhoA p21
93. Post-translational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase
94. Regulation of reversible binding of smg p25A, a ras p21-like GTP-binding protein, to synaptic plasma membranes and vesicles by its specific regulatory protein, GDP dissociation inhibitor
95. Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the rho proteins, ras p21-like small GTP-binding proteins
96. Post-trans-lational modifications of p21rho proteins
97. Posttranslational modification of proteins by isoprenoids in mammalian cells
98. The prenylation of proteins
99. Protein prenylation: key to ras function and cancer intervention?
100. Protein prenylation: more than just glue?
101. Post-translational modifications of the C-terminal region of the rho protein are important for its interaction with membranes and the stimulatory and inhibitory GDP/GTP exchange proteins
102. Role of the C-terminal region of smg p25A in its interaction with membranes and the GDP/GTP exchange protein
103. Somatic mutations in the neurofibromatosis 1 gene in human tumors
104. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells
105. Saccharomyces cerevisiae CDC25 (1028-1589) is a guanine nucleotide releasing factor for mammalian Ras proteins and is oncogenic in NIH3T3 cells
106. Association of sos ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation
107. Transforming and c-fos promoter/enhancer-stimulating activities of a stimulatory GDP/GTP exchange protein for small GTP-binding proteins
108. Ras C-terminal processing enzymes - new drug targets?
109. Small GTP-binding proteins
110. Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function
111. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP
112. The cellular response to induction of the p21c-Ha-ras oncoprotein includes stimulation of jun gene expression
113. Phosphorylation of c-jun mediated by MAP kinases
114. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells
115. Reversal of transformed phenotype by monoclonal antibodies against Ha-ras p21 proteins
116. Requirement for c- ras proteins during viral oncogene transformation
117. Effect of a dominant inhibitory Ha- ras mutation on neuronal differentiation of PC12 cells
118. Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression
119. The Saccharomyces cerevisiae SDC25 C-domain gene product overcomes the dominant inhibitory activity of Ha-ras asn-17
120. Cellular ras activity and tumor cell proliferation
121. Insulin stimulation of gene expression mediated by p21ras activation
122. Accumulation of p21 ras GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity
123. Platelet-derived growth factor stimulates formation of active p21 ras GTP complex in Swiss mouse 3T3 cells
124. Nerve growth factor induces accumulation of the GTP-bound form of p21ras in rat pheochromocytoma PC12 cells
125. NGF and EGF rapidly activate p21ras in PC12 cells by distinct, convergent pathways involving tyrosine phosphorylation
126. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phospho-rylation of p21ras GTPase-activating protein
127. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4
128. Erythropoietin induces p21ras activation and p120GAP tyrosine phsophorylation in human erythroleukemia cells
129. Stimulation of p21ras upon T-cell activation
130. CD2 antigen mediated activation of the guanine nucleotide binding proteins p21ras in human T lymphocytes
131. The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes
132. Interaction of the IL-2 receptor with the src-family kinase p56lck. Identification of novel intermolecular association
133. Nerve growth factor stimulation of the Ras-guanine nucleotide exchange factor and GAP activities
134. Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21ras
135. Missing links between receptors and Ras
136. Binding of GAP to activated PDGF receptors
137. PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex
138. Activation of ras by insulin in 3T3 L1 cells does not involve GTPase-activating protein phosphorylation
139. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactions
140. Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-association proteins, p190 and p62, in c- src overexpressors
141. Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPase-activating protein
142. Molecular cloning of cDNAs encoding the GAP-associated protein p190: implications for a signaling pathway from Ras to the nucleus
143. A cytoplasmic protein inhibits the GTPase activity of H- ras in a phospholipid-dependent manner
144. Cellular ras activity in phospholipid metabolism
145. Regulation of Ras-GAP and the neurofibromatosis-1 gene product by Eicosanoids
146. Phosphorylation of the S. cerevisiae Cdc-25 in response to glucose results in its dissociation from Ras
147. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs
148. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains
149. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
150. An SH3-SH2-SH3 protein is required for p21Ras1 activation and binds to sevenless and sos proteins in vitro
151. Association of the Shc and Grb-2/Sem-5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases
152. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adaptor protein, and Sos nucleotide exchange factor
153. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras
154. Guanine-nucleotide-releasing factor hSosl binds to Grb2 and links receptor tyrosine kinases to Ras signalling
155. A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of ras guanine nucleotide exchange, Sos
156. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
157. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
158. Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases
159. MAP kinase regulation - the oncogene connection
160. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity
161. The role of Raf-1 phosphorylation in signal transduction
162. Serum-, TPA, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase
163. ras mediates nerve growth factor receptor modulation of three signaltransducing protein kinases: MAP kinase, Raf-1, and RSK
164. Raf functions downstream of Rasl in the sevenless signal transduction pathway
165. Biochemical analysis of Torso and D-Raf during Drosophila embryogenesis: implications for terminal signal transduction
166. C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation
167. Complexes of Ras-GTP with Raf-1 and mitogen-activated protein kinase kinase
168. Raf-1 activates MAP kinase-kinase
169. Characterization of downstream elements in a Raf-1 pathway
170. Erks: their fifteen minutes has arrived
171. The mitogen-activated protein kinase activator
172. Activation of mitogen-activated protein (MAP) kinase by a MAP kinase-kinase
173. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro
174. Molecular structure of a protein-tyrosine/threonine kinase activating p42 mitogen-activated protein (MAP) kinase: MAP kinase kinase
175. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product
176. Purification of a murine proteintyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: relationship to the fission yeast byr1 gene product
177. Microtubule-associated protein 2 kinases, ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: implications for their mechanism of activation
178. Kinase cascade conserved
179. A conserved kinase cascade for MAP kinase activation in yeast
180. MAP kinase-related FUS3 from S. cerevisiae is activated by STE7 in vitro
181. FUS3 phosphorylates multiple components of the mating signal transduction cascade: evidence for STE12 and FAR1
182. A protein kinase similar to MAP kinase activator acts downstream of the Raf kinase in Drosophila
183. MAP kinase is constitutively activated in gip2 and src transformed Rat 1a fibroblasts
184. Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and Rat 1a cells
185. A divergence in the MAP kinase regulatory network defined by MEK kinase and raf
186. Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro
187. Signal transduction within the nucleus by mitogen-activated protein kinase
188. Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts
189. Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1
190. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c- fos promoter
191. The role of Raf-1 phosphorylation in signal transduction
192. MAPKAP kinase-2: a novel protein kinase activated by mitogen-activated protein kinase
193. Nuclear localization and regulation of erk- and rsk-encoded protein kinases
194. The ras protein family: evolutionary tree and role of conserved amino acids
195. The ras superfamily of GTP-binding proteins: guidelines on nomenclature
196. Growth-regulated expression of rhoG, a new member of the ras homolog gene family
197. ADP-ribosylation by Clostridium botulinum C3 exoenzyme increases steadystate GTPase activities of recombinant rhoA and rhoB proteins
198. Microinjection of recombinant p21rho induces rapid changes in cell morphology
199. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors
200. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
201. Molecular cloning of cDNAs encoding the GAP-associated protein p190: implications for a signaling pathway from ras to the nucleus
202. Characterization and expression of the human rhoH12 gene product
203. Tumorigenic activity of rho genes from Aplysia californica
204. The ras-related gene rhoB is an immediate-early gene inducible by v-Fps, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts
205. Bcr encodes a GTPase-activating protein for p21rac
206. Multiple BCR-related gene products and their proposed involvement in ligand-induced signal transduction pathways
207. Oncogene ect2 is related to regulators of small GTP-binding proteins
208. MAP kinase by any other name smells just as sweet
209. New intracellular targets for therapeutic drug design
210. Insulin stimulation of gene expression mediated by p21ras activation
211. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active ras GTP complex in rat pheochromocytoma PC12 cells
212. Activation of p21ras by transforming growth factor β in epithelial cells
213. Non-nuclear oncogenes and the regulation of gene expression in transformed cells
214. The ABL-BCR fusion gene is expressed in chronic myeloid leukemia